Extendicare Inc. announced that its Board of Directors has completed its search for a new President and Chief Executive Officer with the appointment of Dr. Michael R. Guerriere effective October 22, 2018. Dr. Guerriere, will be succeeding Tim Lukenda who, as previously announced, is departing the Company. He is currently the Chief Medical Officer, Vice President and Chief Strategy Officer of TELUS Health, where he oversees the strategy for the company's eHealth business which serves clinical professionals, hospitals, government agencies, health authorities, pharmacies and consumers across Canada.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
7.67 CAD | +2.27% | +3.23% | +5.36% |
Apr. 15 | Extendicare Inc. Declares Cash Dividend for the Month of April 2024, Payable on May 15, 2024 | CI |
Mar. 11 | Extendicare Price Target Raised to $8 at RBC | MT |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+5.36% | 457M | |
+20.40% | 84.31B | |
-29.37% | 69.9B | |
+9.65% | 29.06B | |
-8.86% | 17.38B | |
+2.14% | 17.01B | |
+0.24% | 15.35B | |
+7.23% | 12.91B | |
+68.23% | 12.47B | |
+6.43% | 12.26B |
- Stock Market
- Equities
- EXE Stock
- News Extendicare Inc.
- Extendicare Inc. Appoints Dr. Michael R. Guerriere as New President and CEO, Effective October 22, 2018